12 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp02164 | C7A | KILRGVAKKILRTFLRRISKDILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 10.6 ± 0.4 µM |
| dbacp02165 | C7A | KILRGVAKKILRTFLRRISKDILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 13.0 ± 1.0 µM |
| dbacp02166 | C7A | KILRGVAKKILRTFLRRISKDILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 12.1 ± 1.6 µM |
| dbacp02167 | C7A | KILRGVAKKILRTFLRRISKDILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 3.7 ± 4.3 µM |
| dbacp02185 | C7A-D21k | KILRGVAKKIMRTFLRRISKKILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 8.4 ± 0.2 µM |
| dbacp02186 | C7A-D21k | KILRGVAKKIMRTFLRRISKKILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 12.3 ± 2.0 µM |
| dbacp02187 | C7A-D21k | KILRGVAKKIMRTFLRRISKKILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 8.3 ± 0.5 µM |
| dbacp02188 | C7A-D21k | KILRGVAKKIMRTFLRRISKKILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 12.3 ± 1.0 µM |
| dbacp02202 | C7A-Δ | KILRGVAKKIMRTFLRRILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 7.5 ± 0.4 µM |
| dbacp02203 | C7A-Δ | KILRGVAKKIMRTFLRRILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 13.8 ± 2.0 µM |
| dbacp02204 | C7A-Δ | KILRGVAKKIMRTFLRRILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 9.3 ± 1.5 µM |
| dbacp02205 | C7A-Δ | KILRGVAKKIMRTFLRRILTGKK | NK-2 variants | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 13.1 ± 0.9 µM |